Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-05-19
2010-06-08
Cook, Lisa V (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C436S501000, C436S518000
Reexamination Certificate
active
07732151
ABSTRACT:
An assay for determining the ability of an enzyme, functional fragment, or functional derivative thereof to modify the phosphorylation status of a biotinylated polypeptide.
REFERENCES:
patent: 5763198 (1998-06-01), Hirth et al.
patent: WO 95/04136 (1995-09-01), None
patent: WO 96/40276 (1996-12-01), None
patent: WO 98/09169 (1998-03-01), None
patent: WO 99/29894 (1999-06-01), None
patent: WO 00/75167 (2000-12-01), None
Schaefer et al. (Analytical Biochemistry, vol. 261, pp. 100-112, 1998).
Boge et al., A Nonradioactive Assay for the Insulin Receptor Tyrosine Kinase: Use in Monitoring Receptor Kinase Activity after Activation of Overexpressed Protein Kinase C alpha and High Glucose Treatment, Analytical Biochemistry, (1995), vol. 231, pp. 323-332.
Schaefer et al., Detection of Protein Tyrosine Kinase Activity Using a High-Capacity Streptavidin-Coated Membrance and Optimized Biotinylated Peptide Substrates, Analytical Biochemistery, (1998), vol. 261, pp. 100-112.
Siemeister et al., Recombinant Human Insulin Receptor Substrate-1 Protein, The Journal Of Biological Chemistry, (1995), vol. 270, No. 9, pp: 4870-4874.
Aquirre et al., Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action, J. Biol. Chem. vol. 275, 2000, pp. 9047-9054.
Araki et al., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, vol. 372, 1994, pp. 186-190.
Araki at al., Human skeletal muscle insulin receotir substrate-1. Characterization of the cDNA, gene, and chromosomal localization., Diabetes, vol. 42, 1993, pp. 1041-1044.
De Fea et al., Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612, Biochemistry, vol. 36, 1997, pp. 12939-12947.
Eldar-Finkelman et al., Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action, Proc. Natl. Acad. Sci. USA, vol. 94, 1997, pp. 9660-9664.
Freund et al., The P13-kinase serine kinase phosphorylates its p85 subunit in IRS-1 and P13-kinase IRS-1 complexes, Biochem Biophys Res Commun. vol. 206, 1995, pp. 272-278.
Gao et al., Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex, J. Biol. Chem., vol. 277, 2002, pp. 48115-48121.
Jakobsen et al., 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-780 in mouse C2c12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside, J. Biol. Chem., vol. 276, 2001, pp. 46912-46916.
Lavan et al., A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family, J. Biol. Chem., vol. 272, 1997, pp. 21403-21407.
Lavan el al., The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family, J. Biol. Chem., vol. 272, 1997, pp. 11439-11443.
Le Marchand-Brustel, Y., Molecular mechanisms of insulin action in normal and insulin-resistant states, Exp. Clin. Endocrinol. Diabetes, vol. 107, 1999, pp. 126-132.
Mothe et al., Phosphorylation of insulin receptor substrate-1 on multiple serine residues 612, 632, 662 and 731, modulates insulin action, J. Biol. Chem., vol. 271, 1996, pp. 11222-11227.
Paz et al., Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function, J. Biol. Chem., vol. 274, 1999, pp. 28816-28822.
Schmitz-Peiffer et al., Ceramide generation is sufficient to account for the inhibiton of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate, Ann. NY Acad. Sci. vol. 967, 2002, pp. 146-157.
Sun et al., Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein, Nature, vol. 352, 1991, pp. 73-77.
Tanasijevic at al., Phosphorylation of the insulin recetpro substrate IRS-1 by casein kinase II, J. Biol. Chem., vol. 268, 1993, pp. 18157-18166.
Thirone at al., Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues, Endocrinology, vol. 140, 1999, pp. 55-62.
White, M.F., IRS proteins and the common path to diabetes, Am. J Physiol. Endocrinol. Metabl. vol. 283, 2002, pp. E413-422.
Kannt Aimo
Tennagels Norbert
Thuering Harald
Cook Lisa V
Sanofi-Aventis Deutschland GmbH
LandOfFree
Use of IRS-polypeptides for identifying of pharmaceutically... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of IRS-polypeptides for identifying of pharmaceutically..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of IRS-polypeptides for identifying of pharmaceutically... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4247254